Literature DB >> 23273655

Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues.

Christina Fluur1, Kärstin Bolse, Anna Strömberg, Ingela Thylén.   

Abstract

BACKGROUND: ICD deactivation at end-of-life is technically uncomplicated. However, it may present a psychological challenge to healthcare professionals, patients, and next-of-kin.
OBJECTIVE: This study explored patients' experiences of complex issues of battery replacement and deactivation of the ICD.
METHODS: Semistructured interviews were administered to 37 medically stable ICD-recipients.
RESULTS: The ICD-recipients lived with an uncertain illness trajectory, but the majority had not reflected on battery replacement or elective ICD deactivation. Healthcare professionals had rarely discussed these issues with patients. However, this was consistent with the ICD-recipients' wishes. Many patients had misconceptions about the lifesaving capacity of the ICD and the majority stated that they would not choose to deactivate the ICD, even if they knew they were terminally ill, and it meant they would receive multiple shocks.
CONCLUSION: The ICD-recipients tended not to think about end-of-life issues, which imply that many patients reach the final stages of life unaware of the option of ICD deactivation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23273655     DOI: 10.1016/j.hrtlng.2012.11.006

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  9 in total

1.  Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross-sectional study.

Authors:  Mohammad A Zakeri; Nadia Sedri; Golamreza Bazmandegan; Maryam Zakeri; Mohammad Safariyan; Mahlagha Dehghan
Journal:  Health Sci Rep       Date:  2022-06-13

Review 2.  Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.

Authors:  Krystina B Lewis; Dawn Stacey; Dan D Matlock
Journal:  Patient       Date:  2014       Impact factor: 3.883

Review 3.  Perceptions and experiences of patients living with implantable cardioverter defibrillators: a systematic review and meta-synthesis.

Authors:  Sim Leng Ooi; Hong-Gu He; Yanhong Dong; Wenru Wang
Journal:  Health Qual Life Outcomes       Date:  2016-11-17       Impact factor: 3.186

4.  The Challenges of Living With an Implantable Cardioverter Defibrillator: A Qualitative Study.

Authors:  Mohammad Abbasi; Reza Negarandeh; Reza Norouzadeh; Amir Reza Shojae Mogadam
Journal:  Iran Red Crescent Med J       Date:  2016-06-22       Impact factor: 0.611

5.  Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.

Authors:  Jane MacIver; Alana Tibbles; Filio Billia; Heather Ross
Journal:  SAGE Open Med       Date:  2016-04-07

6.  Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks?

Authors:  Ingela Thylén; Debra K Moser; Misook L Chung; Jennifer Miller; Christina Fluur; Anna Strömberg
Journal:  Int J Cardiol Heart Vessel       Date:  2013-11-13

7.  Using co-design to develop an intervention to improve communication about the heart failure trajectory and end-of-life care.

Authors:  Lisa Hjelmfors; Anna Strömberg; Maria Friedrichsen; Anna Sandgren; Jan Mårtensson; Tiny Jaarsma
Journal:  BMC Palliat Care       Date:  2018-06-11       Impact factor: 3.234

8.  Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.

Authors:  Ingela Thylén; Debra K Moser; Anna Strömberg
Journal:  BMC Geriatr       Date:  2018-10-20       Impact factor: 3.921

9.  Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.

Authors:  Mei Ching Lee; Daniel P Sulmasy; Joseph Gallo; Joan Kub; Mark T Hughes; Stuart Russell; Anela Kellogg; Sharon G Owens; Peter Terry; Marie T Nolan
Journal:  Am J Hosp Palliat Care       Date:  2016-03-31       Impact factor: 2.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.